Association of Deja vu With Cardiovascular Diseases

Sarim Rashid1, Raja Ram Khenhrani2, Sapna Devi3

  • 1Department of Surgery, East Lancashire Hospital NHS Trust, Lancashire, UK.

Insights

Recent studies link déjà vu experiences to cardiovascular diseases (CVDs). Potential causes include temporal lobe disruptions or shared genetic factors like the Apolipoprotein E (APOE) gene.

Area of Science:

  • Neurology
  • Cardiology
  • Genetics

Background:

  • Emerging research suggests a correlation between déjà vu and cardiovascular diseases (CVDs).
  • The underlying mechanisms linking these conditions remain largely unexplored.
  • The temporal lobe's role in both memory and cardiovascular regulation is a key area of interest.

Purpose of the Study:

  • To explore the potential association between déjà vu and cardiovascular diseases.
  • To investigate proposed mechanisms, including neurological and genetic factors.
  • To examine the role of the Apolipoprotein E (APOE) gene and psychological factors.

Main Methods:

  • Review of recent studies and existing literature on déjà vu and CVDs.
  • Examination of theories involving temporal lobe function and cardiovascular regulation.
  • Analysis of genetic associations, focusing on the Apolipoprotein E (APOE) gene.
  • Consideration of psychological factors like stress and emotional arousal.

Main Results:

  • Déjà vu may stem from disruptions in the temporal lobe, affecting blood pressure and heart rate regulation.
  • A shared genetic predisposition is hypothesized, with the Apolipoprotein E (APOE) gene implicated.
  • The APOE4 isoform may contribute to CVD through impaired lipoprotein clearance, inflammation, and endothelial dysfunction.
  • Psychological factors, such as stress associated with déjà vu, could also play a role.

Conclusions:

  • Further research is essential to elucidate the complex relationship between déjà vu and cardiovascular diseases.
  • Understanding these links may pave the way for novel diagnostic or therapeutic strategies.
  • Investigating the APOE gene and stress-related pathways could offer insights into managing individuals with both conditions.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
17
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
16
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
58
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
383
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
36